Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joanna Hindley"'
Autor:
Iben Lyskjær, Christopher Davies, Anna‐Christina Strobl, Joanna Hindley, Steven James, Radhesh K. Lalam, William Cross, Geoff Hide, Kenneth S. Rankin, Lee Jeys, Roberto Tirabosco, Jonathan Stevenson, Genomics England Research Consortium, Paul O’Donnell, Paul Cool, Adrienne M. Flanagan
Publikováno v:
Molecular Oncology, Vol 15, Iss 12, Pp 3679-3690 (2021)
Chondrosarcoma (CS) is a rare tumour type and the most common primary malignant bone cancer in adults. The prognosis, currently based on tumour grade, imaging and anatomical location, is not reliable, and more objective biomarkers are required. We ai
Externí odkaz:
https://doaj.org/article/06050dfe09da4f93b0994c5d65b4ce29
Autor:
Paul O'Donnell, Radhesh K Lalam, Steven James, Geoff Hide, Christopher Davies, Roberto Tirabosco, Jonathan Stevenson, Adrienne M. Flanagan, Paul Cool, Iben Lyskjaer, Joanna Hindley, Lee Jeys, William Cross, Anna-Christina Strobl, Kenneth S. Rankin
Publikováno v:
Molecular Oncology
Lyskjær, I, Davies, C, Strobl, A C, Hindley, J, James, S, Lalam, R K, Cross, W, Hide, G, Rankin, K S, Jeys, L, Tirabosco, R, Stevenson, J, O’Donnell, P, Cool, P, Flanagan, A M & Genomics England Research Consortium 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102
Molecular Oncology, Vol 15, Iss 12, Pp 3679-3690 (2021)
Lyskjær, I 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102
Lyskjær, I, Davies, C, Strobl, A C, Hindley, J, James, S, Lalam, R K, Cross, W, Hide, G, Rankin, K S, Jeys, L, Tirabosco, R, Stevenson, J, O’Donnell, P, Cool, P, Flanagan, A M & Genomics England Research Consortium 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102
Molecular Oncology, Vol 15, Iss 12, Pp 3679-3690 (2021)
Lyskjær, I 2021, ' Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations ', Molecular Oncology . https://doi.org/10.1002/1878-0261.13102
Chondrosarcoma (CS) is a rare tumour type and the most common primary malignant bone cancer in adults. The prognosis, currently based on tumour grade, imaging and anatomical location, is not reliable, and more objective biomarkers are required. We ai
Autor:
null Iben Lyskjær, null Christopher Davies, null Anna‐Christina Strobl, null Joanna Hindley, null Steven James, null Radhesh K Lalam, null William Cross, null Geoff Hide, null Kenneth S Rankin, null Lee Jeys, null Roberto Tirabosco, null Jonathan Stevenson, null Genomics England Research Consortium, null Paul O’Donnell, null Paul Cool, null Adrienne M Flanagan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a9065af6a09d31ac09b6bfaa8ec50c8
https://doi.org/10.1002/1878-0261.13102/v2/response1
https://doi.org/10.1002/1878-0261.13102/v2/response1
Autor:
Joanna Hindley, Sarah Montagu
Publikováno v:
Challenges in Midwifery Care ISBN: 9780333609040
Female genital mutilation (FGM) is a traditional practice thousands of years old that affects an estimated 80 000 000 women and young girls world wide. Until recently, it was referred to by the euphemism ‘female circumcision’, which underplayed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ae80431b4d84b1c098f9f69cf9e5153
https://doi.org/10.1007/978-1-349-13425-0_6
https://doi.org/10.1007/978-1-349-13425-0_6